Published in Miner Electrolyte Metab on January 01, 1993
Clinical presentation and outcome in primary familial hypomagnesaemia. Arch Dis Child (1998) 0.98
Familial hypomagnesemia with hypercalciuria and nephrocalcinosis. Pediatr Nephrol (2003) 0.82
Comparison between serum magnesium levels of asphyxiated neonates and normal cases. Med J Islam Repub Iran (2017) 0.75
Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science (1994) 4.27
Criteria for intraventricular conduction disturbances and pre-excitation. World Health Organizational/International Society and Federation for Cardiology Task Force Ad Hoc. J Am Coll Cardiol (1985) 2.28
Focal segmental glomerulosclerosis in a patient homozygous for a CD2AP mutation. Kidney Int (2007) 1.93
Effects of oral and intramuscular vitamin K prophylaxis on vitamin K1, PIVKA-II, and clotting factors in breast fed infants. Arch Dis Child (1992) 1.86
Mutations in the type IV collagen alpha 3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet (1994) 1.69
Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int (1998) 1.66
Vasodilatation produced by apomorphine in the hindleg of the dog. J Pharmacol Exp Ther (1977) 1.63
Identification of COL4A5 defects in Alport's syndrome by immunohistochemistry of skin. Kidney Int (1999) 1.61
The glycosaminoglycan content of renal basement membranes in the congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol (1992) 1.55
Characterization of verocytotoxin-producing Escherichia coli O157 isolates from patients with haemolytic uraemic syndrome in Western Europe. Epidemiol Infect (1995) 1.54
[Prevalence of hemorrhages due to vitamin K deficiency in The Netherlands, 1992-1994]. Ned Tijdschr Geneeskd (1996) 1.54
Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet (1992) 1.51
Effects of verocytotoxin-1 on nonadherent human monocytes: binding characteristics, protein synthesis, and induction of cytokine release. Blood (1996) 1.51
Prevention of vitamin K deficiency in infancy by weekly administration of vitamin K. Acta Paediatr (1993) 1.47
Occurrence of verocytotoxin-producing Escherichia coli O157 on Dutch dairy farms. J Clin Microbiol (1998) 1.47
Isolation and characterization of verocytotoxin-producing Escherichia coli O157 strains from Dutch cattle and sheep. J Clin Microbiol (1998) 1.45
Intraperitoneal administration of recombinant human erythropoietin in children on continuous ambulatory peritoneal dialysis. Eur J Pediatr (1992) 1.44
Screening for microalbuminuria in type 2 diabetic patients: the evaluation of a dipstick test in general practice. Diabet Med (1995) 1.44
Fibrinolytic responses to 1-desamino-8-D-arginine-vasopressin in patients with congenital nephrogenic diabetes insipidus. Nephron (1990) 1.42
On the value of apex cardiography for timing intracardiac events. Am J Cardiol (1971) 1.42
The impact of balloon material and lesion characteristics on the incidence of angiographic and clinical complications of coronary angioplasty. Cathet Cardiovasc Diagn (1994) 1.40
[The magnitude of the 'anion gap']. Ned Tijdschr Geneeskd (1999) 1.39
Adequate dialysis? Measurement of KT/V in a pediatric peritoneal dialysis population. Perit Dial Int (1997) 1.39
[Evaluation of various forms of vitamin-K prophylaxis in breastfed infants]. Ned Tijdschr Geneeskd (1993) 1.37
Dominant isolated renal magnesium loss is caused by misrouting of the Na(+),K(+)-ATPase gamma-subunit. Nat Genet (2000) 1.35
Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int (1997) 1.35
Clinical presentation and follow-up of 30 patients with congenital nephrogenic diabetes insipidus. J Am Soc Nephrol (1999) 1.33
Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood (2000) 1.31
Patients with autosomal nephrogenic diabetes insipidus homozygous for mutations in the aquaporin 2 water-channel gene. Am J Hum Genet (1994) 1.30
Benign familial hematuria due to mutation of the type IV collagen alpha4 gene. J Clin Invest (1996) 1.22
Agrin is a major heparan sulfate proteoglycan in the human glomerular basement membrane. J Histochem Cytochem (1998) 1.20
Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review. Eur J Pediatr (2009) 1.19
Haemolytic-uraemic syndrome. Epidemiological and clinical study. Arch Dis Child (1974) 1.19
Leigh's encephalomyelopathy in a patient with cytochrome c oxidase deficiency in muscle tissue. Pediatrics (1977) 1.18
Monocyte chemoattractant protein-1 and interleukin-8 levels in urine and serum of patents with hemolytic uremic syndrome. Pediatr Res (1998) 1.17
The clinical spectrum of type IV collagen mutations. Hum Mutat (1997) 1.16
Congenital cataract and mitochondrial myopathy of skeletal and heart muscle associated with lactic acidosis after exercise. J Pediatr (1975) 1.15
Biochemical studies in the liver and muscle of patients with Zellweger syndrome. Pediatr Res (1983) 1.13
Dutch medical language processing: discussion of a prototype. Medinfo (1995) 1.12
Prostate cancer among pesticide applicators: a meta-analysis. Int Arch Occup Environ Health (2004) 1.11
Study of the elimination kinetics of torasemide, a novel loop diuretic, in renal insufficiency. Eur J Clin Pharmacol (1986) 1.10
Dopamine-induced neurogenic vasodilatation in isolated perfused muscle preparation of the dog. Naunyn Schmiedebergs Arch Pharmacol (1975) 1.08
Verocytotoxin-producing Escherichia coli infection in hemolytic uremic syndrome in part of western Europe. Eur J Pediatr (1996) 1.07
New mutations in the AQP2 gene in nephrogenic diabetes insipidus resulting in functional but misrouted water channels. J Am Soc Nephrol (1997) 1.05
Occupation related pesticide exposure and cancer of the prostate: a meta-analysis. Occup Environ Med (2003) 1.04
Day-to-day variation of the normal orthogonal electrocardiogram and vectorcardiogram. Circulation (1972) 1.04
Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol (2001) 1.03
The molecular basis of Dutch infantile nephropathic cystinosis. Nephron (2001) 1.02
Autosomal dominant Alport syndrome caused by a COL4A3 splice site mutation. Kidney Int (2000) 1.00
The left ventricular ejection time in elderly subjects. Circulation (1970) 1.00
Emetic and antiemetic effects of opioids in the dog. Eur J Pharmacol (1986) 0.99
Direct vasodilator effects of physiological hyperinsulin-aemia in human skeletal muscle. Eur J Clin Invest (1996) 0.98
Interpretative reporting and alarming based on laboratory data. Clin Chim Acta (1993) 0.98
Dopamine-induced inhibition of synaptic transmission in lumbar paravertebral ganglia of the dog. Naunyn Schmiedebergs Arch Pharmacol (1973) 0.98
Neuronal dopamine receptors on autonomic ganglia and sympathetic nerves and dopamine receptors in the gastrointestinal system. Pharmacol Rev (1985) 0.97
Cognitive and psychosocial functioning of patients with congenital nephrogenic diabetes insipidus. Am J Med Genet (1996) 0.97
Coronary arterial lesions in young men who survived a first myocardial infarction: clinical and electrocardiographic predictors of multivessel disease. Am J Cardiol (1981) 0.96
Persistent arterial hypotension after bilateral nephrectomy in a 4-month-old infant. Pediatr Nephrol (2001) 0.95
Primary structure and high expression of human agrin in basement membranes of adult lung and kidney. Eur J Biochem (1998) 0.95
Low-renin, low-aldosterone hypertension and abnormal cortisol metabolism in a 19-month-old child. Horm Res (1982) 0.95
Plasma cytokine levels in hemolytic uremic syndrome. Nephron (1995) 0.95
Rickets in a preterm infant during intravenous alimentation. Acta Paediatr Scand (1983) 0.94
Isolation and partial characterization of heparan sulphate proteoglycan from the human glomerular basement membrane. Biochem J (1989) 0.93
The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol (1989) 0.91
Detection of tumour DNA in serum of colorectal cancer patients. Scand J Clin Lab Invest (1997) 0.91
Comparison of multigroup logistic and linear discriminant ECG and VCG classification. J Electrocardiol (1987) 0.91
Aberrant splicing of the COL4A5 gene in patients with Alport syndrome. Hum Mol Genet (1994) 0.91
Alanine glyoxylate aminotransferase and the urinary excretion of oxalate and glycollate in hyperoxaluria type I and the Zellweger syndrome. Clin Chim Acta (1987) 0.91
Assessment of the performance of electrocardiographic computer programs with the use of a reference data base. Circulation (1985) 0.90
Renal transplantation in 20 children with hemolytic-uremic syndrome. Clin Nephrol (1990) 0.90
Treatment of hyperhomocysteinemia in children on dialysis by folic acid. Pediatr Nephrol (1999) 0.89
Dopamine-induced neurogenic vasodilatation: antagonism at the vascular level. Arch Int Pharmacodyn Ther (1973) 0.89
Role of bacteria in the pathogenesis of short bowel syndrome-associated D-lactic acidemia. Microb Pathog (1997) 0.89
Survivin mRNA expression is elevated in malignant urothelial cell carcinomas and predicts time to recurrence. Anticancer Res (2003) 0.89
Reversible deficient prostacyclin release in childhood hemolytic uremic syndrome. Int J Pediatr Nephrol (1982) 0.89
Multivariate survival analysis for the assessment of prognostic factors and risk categories after recovery from acute myocardial infarction: the Belgian situation. Am J Epidemiol (1985) 0.89
Nephrogenic diabetes insipidus: clinical symptoms, pathogenesis, genetics and treatment. Pediatr Nephrol (1992) 0.89
Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol (2001) 0.88
Biochemical studies in the cerebro-hepato-renal syndrome of Zellweger: a disturbance in the metabolism of pipecolic acid. J Inherit Metab Dis (1980) 0.88
Linkage of Gitelman syndrome to the thiazide-sensitive sodium-chloride cotransporter gene with identification of mutations in Dutch families. Pediatr Nephrol (1996) 0.88
Argininosuccinic aciduria: clinical and biochemical findings in three children with the late onset form, with special emphasis on cerebrospinal fluid findings of amino acids and pyrimidines. Neuropediatrics (1993) 0.88
Severe linear growth retardation in rural Zambian children: the influence of biological variables. Am J Clin Nutr (2000) 0.88
Acyl-CoA oxidase activity and peroxisomal fatty acid oxidation in rat tissues. Biochim Biophys Acta (1988) 0.88
Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation. Hum Genet (1995) 0.88
Gastric relaxation and vomiting by apomorphine, morphine and fentanyl in the conscious dog. Eur J Pharmacol (1981) 0.88
The effect of di(ethylhexyl)phthalate on fatty acid oxidation and carnitine palmitoyltransferase in various rat tissues. Biochim Biophys Acta (1990) 0.88
Renal biopsy and family studies in 65 children with isolated hematuria. Acta Paediatr Scand (1990) 0.87
Recent insights into the structure and functions of heparan sulfate proteoglycans in the human glomerular basement membrane. Nephrol Dial Transplant (1999) 0.87
Dichlorvos and carcinogenicity: a systematic approach to a regulatory decision. Regul Toxicol Pharmacol (2000) 0.86
Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta (1989) 0.86
Colocalization of the gene for nephrogenic diabetes insipidus (DIR) and the vasopressin type 2 receptor gene (AVPR2) in the Xq28 region. Genomics (1992) 0.86
2,8-Dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency. J Urol (1996) 0.86
Microalbuminuria in patients with Type 2 diabetes mellitus from general practice: course and predictive value. Diabet Med (2001) 0.86
Verocytotoxin inhibits mitogenesis and protein synthesis in purified human glomerular mesangial cells without affecting cell viability: evidence for two distinct mechanisms. J Am Soc Nephrol (1997) 0.86
Toxicokinetics of methyl parathion and parathion in the dog after intravenous and oral administration. Arch Toxicol (1983) 0.86